KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Raw Materials (2016 - 2026)

CareDx's Raw Materials history spans 14 years, with the latest figure at $11.6 million for Q1 2026.

  • On a quarterly basis, Raw Materials fell 15.17% to $11.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $11.6 million, a 15.17% decrease, with the full-year FY2025 number at $13.2 million, up 20.84% from a year prior.
  • Raw Materials hit $11.6 million in Q1 2026 for CareDx, down from $13.2 million in the prior quarter.
  • Over the last five years, Raw Materials for CDNA hit a ceiling of $13.9 million in Q2 2025 and a floor of $9.6 million in Q3 2024.
  • Historically, Raw Materials has averaged $11.4 million across 5 years, with a median of $11.3 million in 2022.
  • Biggest five-year swings in Raw Materials: skyrocketed 41.89% in 2025 and later dropped 15.17% in 2026.
  • Tracing CDNA's Raw Materials over 5 years: stood at $12.0 million in 2022, then decreased by 11.22% to $10.6 million in 2023, then grew by 2.53% to $10.9 million in 2024, then rose by 20.84% to $13.2 million in 2025, then decreased by 11.68% to $11.6 million in 2026.
  • Business Quant data shows Raw Materials for CDNA at $11.6 million in Q1 2026, $13.2 million in Q4 2025, and $13.7 million in Q3 2025.